Teladoc Health cuts 2026 revenue forecast amid insider stock sale and BetterHelp struggles

Teladoc Health's BetterHelp segment saw an 11.6% revenue drop and a near-zero profit margin in Q2 2026, partly due to a shift from cash to insurance payments. The company lowered its full-year 2026 revenue guidance to $2.36-$2.45 billion from $2.48-$2.58 billion. Additionally, BetterHelp's president sold all his shares, and a potential securities fraud investigation has been launched. Despite challenges, Teladoc's stock may be undervalued based on its forward Price-to-Sales ratio below industry average.